Codes / ICD10CM / T48.3X

T48.3X Poisoning by, adverse effect of and underdosing of antitussives

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Poisoning by, adverse effect of and underdosing of antitussives

Summary

This condition encompasses poisoning, adverse effects, or underdosing related to antitussive medications, which are used to suppress coughing. It includes clinical outcomes from exposure to these drugs, whether due to accidental or intentional overdose, therapeutic errors, or insufficient dosing.

Causes

Exposure to antitussives can result from accidental ingestion, incorrect administration, drug interactions, or intentional misuse. Underdosing may occur from dosing errors, patient non-adherence, or pharmacokinetic factors affecting drug levels.

Risk Factors

  • Use of medications with narrow therapeutic windows (e.g., opioid antitussives).
  • Lack of proper storage or labeling of medications.
  • History of substance misuse or accidental exposure in children or vulnerable populations.
  • Concurrent use of multiple drugs with overlapping respiratory or central nervous system effects.
  • Renal or hepatic impairment affecting drug metabolism.

Symptoms

  • Drowsiness, dizziness, or confusion.
  • Nausea, vomiting, or gastrointestinal distress.
  • Respiratory depression or difficulty breathing (especially with opioid antitussives).
  • Headache or blurred vision.
  • Signs of underdosing, such as persistent coughing despite treatment.

Diagnosis

Clinical evaluation focuses on symptoms, medication history, and dosage details. Laboratory tests may assess drug levels or organ function. Monitoring of respiratory status might be used to confirm effects.

Treatment Options

  • Discontinuation or adjustment of the antitussive agent.
  • Supportive care for symptoms (e.g., airway management for respiratory depression).
  • Administration of antidotes if applicable (e.g., naloxone for opioid overdose).
  • Monitoring for complications or adverse reactions.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, timely intervention, and underlying health status. Follow-up may involve monitoring for delayed effects or recurrence of symptoms, especially with long-acting formulations.

Complications

  • Respiratory failure (with severe poisoning).
  • Central nervous system depression.
  • Gastrointestinal distress or dehydration.
  • Cardiovascular instability (e.g., hypotension).

Lifestyle & Prevention

  • Store medications securely to prevent accidental ingestion.
  • Follow dosing instructions carefully and avoid combining antitussives with other sedating substances.
  • Use child-resistant packaging and educate caregivers on safe medication handling.
  • Report any adverse effects promptly to healthcare providers.

When to Seek Professional Help

Seek immediate medical attention for symptoms of poisoning (e.g., severe drowsiness, difficulty breathing) or if underdosing leads to worsening cough or respiratory distress. Contact a provider for persistent or unexplained side effects.

Tips for Medical Coders

Document the specific antitussive agent involved, the intent of exposure (accidental, intentional, therapeutic), and whether the event represents poisoning, an adverse effect, or underdosing. Include details on clinical manifestations and treatment to support code assignment.

Book a walkthrough

T48.3X policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.